Calendar Sienna Biopharmaceuticals, Inc.

Equities

SNNAQ

US82622H1086

Market Closed - OTC Markets Other stock markets 17:16:25 10/05/2024 BST			5-day change	1st Jan Change
0.000001 ^USD	-.--%		-.--%	-.--%

2021	Motion for Asset Sale Approved for Sienna Biopharmaceuticals, Inc.	CI
2021	Avro Life Sciences, Inc. entered into an agreement to acquire Certain Assets of Sienna Biopharmaceuticals, Inc. (OTCPK:SNNA.Q) for $0.1 million.	CI

Chart calendar Sienna Biopharmaceuticals, Inc.

b91dab4d0f2780.LXi3Sv2XRY9VJS4V-Jbubvv_k_DwQfGr-9x611WAstM.FDnEJcr8CccmTl1fycyoGpO6pZS1EanbpLBI4SWy47ZXN_8HmNR0_g1KTQ~ffed3443ac1edd70850facb2e812ef10

Upcoming events on Sienna Biopharmaceuticals, Inc.

No events available

Past events on Sienna Biopharmaceuticals, Inc.

08/10/2020	Interim 2020 Earnings Release
25/06/2019 18:40	BMO Prescription for Success Healthcare Conference
15/06/2019 07:00	World Dermatology Congress - SNA-120
30/05/2019 19:00	Annual General Meeting
23/05/2019 08:30	Dermatology Drug Development Summit
22/05/2019 14:35	Dermatology Drug Development Summit
22/05/2019 08:00	Dermatology Drug Development Summit - Panel
15/05/2019 23:55	Bank of America Merrill Lynch Health Care Conference
07/05/2019	Q1 2019 Earnings Release
13/03/2019	FY 2018 Earnings Release
11/03/2019 15:20	Cowen & Co. Health Care Conference
09/01/2019 19:00	J.P. Morgan Healthcare Conference
06/01/2019 23:20	Dermatology Summit
12/12/2018 15:20	BMO Prescriptions for Success Healthcare Conference
30/07/2018 13:15	SNA-001 Acne Pivotal Trial Results Call
20/06/2018 13:00	JMP Securities Life Sciences Conference
06/06/2018 21:00	Jefferies Global Healthcare Conference
01/06/2018 18:00	Annual General Meeting
15/05/2018 21:40	Bank of America Merrill Lynch Health Care Conference
14/05/2018 14:05	Q1 2018 Earnings Release

Annual results

Fiscal Period	December	2017	2018
Net sales Million USD	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -
EBITDA Million USD	Released Forecast Spread	-48,5 -49,8 2.61%	-76,3 -74,5 -2.47%
EBIT Million USD	Released Forecast Spread	-48,6 -48,5 -0.08%	-76,5 -74,5 -2.68%
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-50,8 -56,7 10.34%	-73,5 -71,0 -3.48%
Net income Million USD	Released Forecast Spread	-50,5 -56,5 10.54%	-73,5 -71,0 -3.48%
EPS USD	Released Forecast Spread	-5,19 -5,72 9.27%	-3,59 -3,49 -2.87%
Announcement Date		15/03/18	14/03/19

Upcoming sector events for Sienna Biopharmaceuticals, Inc.

23/07/2024	VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
24/07/2024	BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
25/07/2024 06:00	ARGENX SE: Q2 2024 Earnings Release
29/07/2024	RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024	NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024	CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024	CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024	SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024	XENCOR, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024	SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)

More events

Past sector events for Sienna Biopharmaceuticals, Inc.

05/06/2024 08:51	PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release
17/05/2024 12:00	AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
16/05/2024 12:46	BIOCON LIMITED: Q4 2024 Earnings Release
16/05/2024 06:00	ZEALAND PHARMA A/S: Q1 2024 Earnings Release
15/05/2024	LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
15/05/2024 13:05	THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
15/05/2024 12:00	CABALETTA BIO, INC.: Q1 2024 Earnings Release
14/05/2024	TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
14/05/2024 21:05	ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024 21:00	ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release